Background Hip arthroscopy is now commonly used to treat hip pain and pathology, including osteoarthritis (OA). Despite this, little is known about the effect of hip arthroscopy on outcomes of pain and function and progression to total hip arthroplasty (THA) in hip OA. Questions/purposes This systematic review aimed to (1) determine pain and function outcomes after hip arthroscopy in people with hip OA; (2) compare the outcome after hip arthroscopy between people with and without hip OA;
Introduction
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Electronic supplementary material The online version of this article (doi:10.1007/s11999-014-3943-9) contains supplementary material, which is available to authorized users. related to hip OA, a focus of surgical intervention is shifting to preventive, minimally invasive arthroscopic techniques [39, 40] in people with early hip OA and coexisting pathology (eg, labral tears, femoroacetabular impingement [FAI] ) [14, 29, 46] . This shift is driven by suggestions that the presence of FAI and/or labral pathology is strongly associated with an increased risk of hip OA and THA in later life [1, 42] ; and hip arthroscopy in people with painful FAI and/or labral pathology may reduce future development of hip OA [41] . However, there is little evidence supporting the notion that undergoing arthroscopy can suppress the development of hip OA and the need for THA in later life [41] . Given the frequency with which hip arthroscopic surgery is now performed in people with early hip OA [39, 40] , it is important to understand the implications of such procedures on symptoms and functional ability.
Recent systematic reviews report worse outcomes in those with coexisting radiographic hip OA or cartilage disease identified during hip arthroscopic surgery for labral pathology [7] and FAI [29, 41] compared with those without degenerative change. However, no systematic review has evaluated outcomes for combinations of various pathologies. Moreover, previous systematic reviews have excluded studies in which hip arthroscopy is specifically performed for hip OA [29] and, hence, the effects of hip arthroscopy for those with hip OA is not known. Finally, the effect of hip arthroscopy on progression to THA and factors associated with progression to THA in people with hip OA have not been reviewed.
This systematic review addresses these gaps in the literature with the aims to (1) determine pain and physical function outcomes after hip arthroscopy in people with hip OA; (2) compare outcome after hip arthroscopy between people with and without hip OA; and (3) report the likelihood of progression to THA in people with hip OA after hip arthroscopy.
Materials and Methods
The systematic review protocol was developed in accordance with the PRISMA statement [34] . Literature search criteria and methods were proposed and agreed on by two authors (JLK, KMC) and were established a priori to minimize selection bias.
Eligibility Criteria
Studies were eligible for inclusion if they used participants aged C 17 years who had undergone hip arthroscopy as a primary intervention for hip OA (defined as chondropathy at the time of surgery or radiographic hip OA on preoperative scans). Studies following participants for at least 3 months, using patient-reported outcome measures of pain and/or function, reporting prevalence of THA, or time to THA were included. All quantitative study designs were considered, including randomized controlled trials (RCTs) and prospective or retrospective approaches (minimum Level IV evidence) [47] . Studies were excluded if they performed open surgeries as the primary intervention; did not include hip OA within the results or failed to specify the surgical procedure performed; were case series with less than 10 participants; published abstracts; nonpeerreviewed; or published in a language other than English.
Search Strategy
A comprehensive, reproducible search strategy was performed on the following databases between January 1990 and March 2014: Scopus, Medline, CINAHL, PubMed, Ausport, SportsDiscus, PEDro, PsychINFO, and Google scholar (Appendix 1 [Supplemental materials are available with the online version of CORR 1 .]). January 1990 was selected as the earliest retrieval record as a result of the paucity of literature on hip arthroscopic surgery before this date [29] . Reference lists of appropriate studies were manually searched for relevant papers.
Titles and abstracts were screened for relevant studies by two independent reviewers (JLK, DM). Any disagreements regarding inclusion were resolved by an independent arbitrator (KMC). Full text versions of identified papers were then retrieved for final eligibility screening by a single reviewer (JLK).
Quality Evaluation
The Downs and Black checklist [4, 13] was used to appraise the methodological quality of included studies (see Appendix 2 for checklist [Supplemental materials are available with the online version of CORR 1 .]). This has adequate reliability and validity for assessing nonrandomized studies [12, 13, 49] . The original 27 items were modified to 17 items following the exclusion of criteria 9, 13, 14, 17, 19, 22, 23, 24, 26 , and 27, which were not applicable for nonrandomized studies [4] . Included studies were rated by three independent reviewers (JLK, NJC, ALH) blinded to author, affiliations, and publishing journal. Any disagreements among reviewers were discussed in a consensus meeting and an independent arbitrator (KMC) used when consensus could not be met. Studies scoring positively on at least 50% of items (nine or more items) were considered to have a sufficiently low risk of bias and were included in subsequent analyses [29] .
Data Management and Statistical Analysis
Eligible papers were grouped where possible based on (1) whether a between-group comparison (hip OA versus no hip OA) was undertaken; and (2) where likelihood of subsequent progression to THA was reported. Interrater agreement on the included Downs and Black criteria was evaluated using the j statistic [23] . Data from included studies were extracted by one reviewer (JLK). Population characteristics (age, sex, type and description of hip OA, duration of symptoms) and details of outcome measures, length of followup, and surgical intervention undertaken were collated. Standardised mean differences (SMDs) were calculated to determine the magnitude of the effect of the intervention within groups or between groups and were calculated as the mean difference between preoperative and followup measures divided by the within-group preoperative SD [47] . SMD magnitude was interpreted as: C 0.8 large effect; 0.5 to 0.79 moderate effect; and 0.2 to 0.49 weak effect [10, 11, 47] . Ninety-five percent confidence intervals for SMDs were calculated [5] using central t-distribution, where the 95% confidence interval = SMD ± 1.96 9 SE of the SMD. Where SMDs could not be calculated, study conclusions were presented. All statistical analyses were conducted using SPSS software Version 21.0 (SPSS Inc, Chicago, IL, USA).
Results

Search Strategy
One hundred thirty-nine studies were identified for evaluation beyond title level and 53 papers for full-text evaluation, following which 18 studies were excluded ( Fig. 1 ). Thirty-five studies fulfilled all eligibility criteria and underwent critical appraisal.
Methodological Quality
Initial overall agreement between the independent raters was substantial (j = 0.687) (agreement on 480 of 595 [81%] items) [31] . Consensus was reached on all 115 remaining items following discussion. Methodological quality scores of the 35 included studies varied from 1 [45] to 15 [44] out of 17 points (mean 9.4 [SD 3.0]) (Appendix 3 [Supplemental materials are available with the online version of CORR 1 .]). Twenty-two papers received a score of 9 or more points and were included in further analyses, whereas the remaining 13 studies were excluded. All included papers were Level IV evidence (case series), with the exception of three studies, which were Level III (casecontrol studies) evidence [14, 16, 37] .
Participants
Participant characteristics were heterogeneous in the 22 studies. Sample sizes ranged from 13 [26] to 560 [14] participants and the percentage of women ranged from 20% [21] to 65% [35] . Mean age across all studies was 40 years (range, 29 [38] to 58 years [22] ). All studies defined hip degenerative disease as chondral pathology seen at arthroscopy and/or preoperative hip degenerative changes observed on radiographs. In 18 studies reporting symptom duration before surgery, the mean duration was 27 months (range, 3 months [25] to 13 years [36] ). Outcome Scores Several patient-reported outcome measures were reported. The modified Harris hip score (mHHS) was most frequently used (13 studies) and is reliable in hip arthroscopy populations, although it demonstrates ceiling effects and poor content validity [30] . The Non-arthritic Hip Score (NAHS) was used in eight studies. It has reported reliability and validity after hip arthroscopy, although its responsiveness is unknown [53] . The Hip Outcome Score (HOS) was used by two studies. Whereas the HOS has good reliability and responsiveness, it has reduced content validity and a ceiling effect in a hip arthroscopy population [30] . Two papers used the WOMAC and pain visual analog scale, although their psychometric properties in a hip arthroscopy population are unknown [29] . One study used a measure that lacked demonstrated psychometric properties, asking participants to rate their pain on a 3-point Likert scale (better, same, worse) [22] .
Outcomes of Hip Arthroscopy for Hip Osteoarthritis
Of the 22 studies, 15 examined pre/post outcomes for hip arthroscopy in people with hip OA without comparison to a control group (Table 1) . The mean ± SD methodological quality score of these 15 papers was 11 ± 2 (range, 9-13 points) out of a possible 15 points. Nine papers prospectively followed participants [8, 9, 16, 22, 24, 29, 46, 51, 55] , whereas six were retrospective; no studies used a RCT design. Eleven studies defined hip OA based on chondral pathology at surgery [8, 9, 16, 21, 24, 26, 36, 37, 46, 51, 55] , whereas six [16, 20-22, 24, 46] classified subjects based on preoperative radiographic disease in combination with articular cartilage disease observed at the time of surgery. Surgical intervention for hip degenerative disease included débridement of chondropathy, microfracture, use of fibrin adhesive, synovectomy, and removal of loose bodies. Corrective surgery for FAI included femoral and acetabular osteoplasty. Followup ranged from 12 months [55] to 13 years [36] . SMDs could be calculated for three studies [21, 35, 55] (Fig. 2) .
Chondral Débridement
Seven studies examined the effects of chondral débridement as an isolated intervention [9, 20, 22, 27, 35, 37, 51] .
Within-subject SMDs could be calculated for one study only. Margheritini and Villar [35] reported a significant moderate SMD of 0.65 (95% confidence interval [CI], 0.54-0.76) on the mHHS at 18 months after surgery.
McCormick et al. [37] showed that the likelihood of a poor outcome at 4 years was 2.5 times greater if chondral disease equaled Outerbridge Grade IV. Similarly, Streich and Schmitt [52] reported an improvement in pain and function of 24 points on the mHHS for the less severe OA group (Outerbridge 0-1), which was not observed in the severe OA (Outerbridge [ 1) group.
Microfracture and Chondral Débridement
Of the six studies that examined the effect of microfracture [8, 20, 24, 26, 36, 46] , five included chondral débridement during corrective surgery for FAI. Moderate to large within-group SMDs were determined ranged from 0.67 (95% CI, 0.52-0.81) (mHHS, Outerbridge Grade II) to 1.14 (0.76-1.52) (NAHS, Outerbridge Grade I) at 22 months followup for a single study [21] . SMDs could not be calculated for the remaining studies as a result of insufficient data, and their reported results were inconsistent. Major improvements were reported by three studies [46] . Two studies reported 40% to 50% of patients had converted to THA at (3-10 years) followup [24, 36] .
Fibrin Adhesive for Chondral Flaps
The one study examining outcomes after the use of fibrin adhesive to repair acetabular chondral flaps reported a large SMD (1.05 [0.58-1.52]) for mHHS at 12 months [55] .
Autologous Chondrocyte Transfer
Fontana et al. [16] compared the effects of autologous chondrocyte transfer (ACT) and chondral débridement in participants with mild hip OA on preoperative radiographs (Tönnis Grade I-II) and cartilage disease classified as Outerbridge Grade III to IV that was greater than 2 cm 2 in area. Those who received ACT had significantly (p \ 0.001) greater improvements in mHHS (40 points) at 74 months followup compared with the chondral débridement group (8 points) [16] .
Comparison of Outcomes of Hip Arthroscopy Between People With and Without Hip Osteoarthritis
Five studies directly compared hip arthroscopy outcomes between people with and without hip OA ( Table 2) . Three studies were prospective in design [14, 44, 50] with a mean ± SD quality score of 12 ± 2 (range, [9] [10] [11] [12] [13] [14] [15] . Hip OA was classified based on chondropathy severity at surgery in two studies [14, 44] and preoperative radiographic changes using the Tönnis grading system [54] in three studies [45] [46] [47] . SMDs could be calculated for three papers [14, 17, 50] to determine within-group effects ( Fig. 3 ) and betweengroup effects (Fig. 4) . Larger within-group SMDs (range, 0.82-2.36) were observed for those having arthroscopy without OA than for those with OA (range, 0.44-1.63) ( Fig. 3) [14] . When between-group SMDs were calculated for the three studies, each study demonstrated moderate to large SMDs between the groups for the patient-reported outcomes, favoring the no hip OA group (Fig. 4 ).
Likelihood of Progression to THA in People With Osteoarthritis Who Undergo Hip Arthroscopy
Nine studies reported progression to THA as an outcome measure ( Table 3 ). The mean modified Downs and Black score was 11 ± 2 points. The mean time to THA progression ranged from 7 months [35] to 4.8 years [36] . Older age was identified as a risk factor for progression to THA in two of the three studies that measured it as a risk factor [19, 36] (Table 3) . McCarthy et al. [36] observed that people aged older than 40 years were 3.6 times more likely to progress to THA. Haviv and O'Donnell [19] observed that in patients with chondropathy graded as Outerbridge IV, older age was associated with a likelihood of a more rapid progression to THA (Pearson's correlation coefficient [r] = À0.34).
More severe chondral disease increased the risk of THA in all papers that evaluated it as a risk factor. The likelihood of progression was 20 times greater with acetabular chondral disease (Outerbridge Grades III and IV) and 58 times greater with femoral chondral disease (Outerbridge Grades III and IV) [36] , whereas greater severity of chondropathy was correlated with increased THA risk (r = À0.35) [19] . Horisberger et al. [24] also reported that time from arthroscopy to THA was 1.2 years in a cohort (mean age, 47 years; 20% women) with Outerbridge Grade II to IV chondropathy. Similarly, the likelihood of conversion to THA was 39 times greater if preoperative radiographic joint space was \ 2 mm [46] . Larson et al. [32] reported that joint space narrowing (JSN) (p = 0.014) and longer duration of symptoms (p = 0.015) predicted higher likelihood of conversion to THA.
Adverse Events
Adverse events were reported in six studies [8, 16, 27, 32, 44, 50] . Collectively, 27 of 435 participants (6%) experienced an adverse event, including transient pudendal nerve (n = 5), lateral femoral cutaneous nerve (n = 6), and 
Discussion
This systematic review evaluated outcomes after hip arthroscopy in people with and without hip OA and examined the risk of progression to THA. Included studies demonstrated considerable variability in methodological quality, sample size, definition of hip OA, surgical intervention, and followup times, which limited opportunities for meta-analysis. Our findings suggest that in people with hip OA, hip arthroscopy has a moderate to large effect, indicating an improvement of patient-reported outcomes after hip arthroscopy, although positive effects may be inflated as a result of methodological limitations of the included studies. However, the between-group effect sizes imply that people with no OA have a substantially larger positive benefit in pain and function after hip arthroscopy than those with hip OA. The average time to THA was 2 years (range, 7 months to 5 years) after hip arthroscopy in those with hip OA. Increasing age and severity of hip OA were associated with a higher likelihood and more rapid progression to THA. Notably, these findings were consistent across a range of surgical procedures. Several methodological limitations in the studies included in this review require consideration. Included studies demonstrated considerable variability in methodological quality, sample size, definition of hip OA, surgical intervention, and followup times. This variability limited opportunities for meta-analysis. There was also no opportunity to perform a sensitivity analysis given the lack of meta-analyses undertaken. The variability also restricted the direct comparisons between studies. Furthermore, the reported improvements are likely to be affected by bias, including lack of blinding of participants and surgeons, lack of randomization to a sham surgery or nonsurgical control group, and lack of reporting of characteristics of nonincluded patients, preventing the reader from determining whether the included subjects accurately represented a population of people with hip OA. These biases are difficult to overcome in surgical studies, but confidence in the reported findings is reduced by their presence. As a result of the absence of required data, SMDs could only be calculated for six studies. Overall, the methodological quality of the majority of included studies was moderate at best, which limits the robustness of findings.
We chose to include studies that examined patients aged 17 years and older. Although this age range is wide, it was used to reflect contemporary clinical practice, where findings of chondropathy are reported in this younger age group and therefore warrant evaluation. We also included studies with OA defined from preoperative radiographs and with chondropathy seen at arthroscopy. Although these definitions are different, we feel that they reflect the continuum of degenerative hip disease. Radiographic change reflects advanced OA only and does not capture degenerative joint disease in its early stages [48] . As such, both warrant inclusion in this systematic review.
When considering the effect of hip arthroscopy in people with hip OA, there were moderate to large SMDs in patient-reported outcomes observed. Thus, it appears that people with hip OA or chondropathy may derive benefits from such surgeries. However, such reported improvements are likely to be affected by biases outlined previously. Future studies examining hip arthroscopy for hip OA such as those of RCT design are required to confirm that the moderate to large positive effects reported in this systematic review are genuine and that hip arthroscopy can offer an improvement in pain and function in people with this burdensome disease. Age also appears to impact on outcomes for hip arthroscopy in people with hip OA. McCormick et al. [37] reported the likelihood of poor outcome was seven times higher in patients aged older than 40 years. It is uncertain whether this effect is the result of more advanced degenerative change or other changes in self-reported pain and function associated with older age. Physical function has been demonstrated to be associated with age in a general elderly population [6] and in people after THA [43] . It is possible that poorer outcomes in older people with hip OA may be associated with advancing age; however, this requires further investigation.
When surgical procedures for hip OA were combined with surgical correction for FAI, results were varied and appear to depend how FAI was treated. When treating patients with cam FAI only, large within-subject effect sizes [21] and large postoperative improvements [26] were reported regardless of the degree of cartilage disease at surgery. This suggests that patients with cam-type FAI have good short-term outcomes (ie, up to 30 months) regarding pain and physical function regardless of degree of chondral damage. In contrast, studies where cam and pincer FAI were combined reported a high conversion rate to THA and worse outcomes when preexisting radiographic hip OA, radiographic JSN, or coexisting cartilage disease were present [24, 46] . These findings suggest that cam and pincer FAI may affect intraarticular loads within the hip differently, resulting in varied outcomes when treated. The effect of FAI type and its surgical correction on outcomes is unclear and requires further investigation.
Emerging arthroscopic interventions such as fibrin adhesive and ACT demonstrate large SMDs and small CIs at 12 months in people with hip OA and acetabular cartilage delamination. Although these techniques show promise in patients with contained severe chondral lesions, high-quality comparative studies are required to confirm findings. Ideally, such studies should be a RCT design to minimize bias with longer-term followup. Those additional studies are particularly important given findings in the knee, where initial reports of such techniques were positive, but findings were unable to be confirmed with robust clinical trials [56] .
When comparing the effects of hip arthroscopy in people with hip OA with those without hip OA, positive effects were smaller in those with hip OA. In the majority of studies, larger within-group SMDs were reported for those without hip OA compared with those with hip OA when groups were classified based on preoperative radiographic degeneration or chondral pathology of greater severity [14, 18, 50] . This finding is supported by the between-group SMDs for outcomes presented in Fig. 4 , in which a substantially larger positive benefit of hip arthroscopy was reported in all three studies [14, 18, 50] . However, Palmer et al. [44] , the study with the highest methodology quality score and the longest followup time of almost 4 years, did not find a difference in within-group outcomes for either group, and each group experienced significant improvement (p \ 0.001). Therefore, it is possible that over a longer time period, people with hip OA and without OA will gain a similar benefit from hip arthroscopy. Moreover, those with hip OA may have a slower recovery than those without after hip arthroscopy. However, more studies with longer-term followup are required to confirm this finding. Importantly, survivorship in avoiding THA was surprisingly low. The overall mean time to THA was 2 years in patients with hip OA who progressed to THA. In the study with the longest followup (13 years), 33% of all patients with hip OA had progressed to THA by 5 years [36] . Furthermore, the survivorship appears to differ, depending on the severity and location of cartilage disease. More severe chondropathy was a consistent predictor of progression to THA [36] . In addition, the odds of an individual requiring a THA was substantially higher if cartilage disease was femoral rather than acetabular [36] . Age also appeared to influence the likelihood of progression to THA, with people aged older than 40 years being 3.6 times more likely to progress to THA [36] and seven times more likely to have a poor outcome after hip arthroscopy [37] . However, these observations may not be independent of degenerative change severity, ability or motivation to complete postsurgical rehabilitation, or changes in self-reported pain and function associated with older age [6] . Clinicians should consider that older patients with more severe disease are more likely to require THA after arthroscopy and should consider this when undertaking postarthroscopic rehabilitation.
Guidelines for the management of hip OA highlight the importance of nonsurgical management, including education, weight management, and targeted exercise programs addressing specific physical impairments [58] . This review confirms that outcomes for hip arthroscopy are less satisfactory when OA has advanced. Although no studies have provided a direct comparison between surgical and nonsurgical OA hip interventions [29] , evidence at the knee suggests that surgical treatment of OA and meniscal degeneration does not provide superior outcomes to nonsurgical interventions [28] . Thus, it is plausible that, for those with hip degenerative disease, hip arthroscopy may not provide benefits beyond those likely with a nonsurgical approach. Future comparative studies are essential to determine the efficacy of nonsurgical and surgical approaches and to differentiate the effects on outcomes in those with early versus late-stage disease.
In conclusion, this review found that patients with hip OA derive a moderate to large benefit in pain and functional outcomes from hip arthroscopy, at least in the short term, although positive effects may be inflated as a result of methodological limitations of the included studies. In addition, this benefit is smaller than that for people with less severe OA or no hip OA. This appears to be irrespective of the interventions performed. The likelihood of progression to THA after hip arthroscopy occurred on average within 2 years for those who progressed. Chondropathy severity and patient age were associated with a higher risk and more rapid progression to THA after hip arthroscopy. Notably, adverse events appear to be few and transient. However, the efficacy of hip arthroscopy compared with nonsurgical interventions for pain and function in people with hip OA is needed to be confirmed through high-quality, comparative studies.
